While melanoma cells often behave differently within the tumour microenvironment compared to cultured cells, it is possible that BRN2 and NFIB regulate additional genes that counteract the growth phenotype that might be anticipated with high EZH2 expression. This evidence concerns the gene NFIB and melanoma.